ADJUVANT CHEMOTHERAPY IN PRIMARY TREATMENT OF OSTEOGENIC SARCOMA

被引：0
|
作者：
SUTOW, WW
SULLIVAN, MP
FERNBACH, DJ
机构：
[1] MD ANDERSON HOSP & TUMOR INST,HOUSTON,TX 77025
[2] BAYLOR COLL MED,HOUSTON,TX 77025
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1974年 / 15卷 / MAR期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：20 / 20
页数：1
相关论文
共 50 条
  • [1] ADJUVANT CHEMOTHERAPY FOR PRIMARY OSTEOGENIC-SARCOMA
    CORTES, EP
    HOLLAND, JF
    SURGICAL CLINICS OF NORTH AMERICA, 1981, 61 (06) : 1391 - 1404
  • [2] ADJUVANT CHEMOTHERAPY IN PRIMARY TREATMENT OF OSTEOGENIC SARCOMA - SOUTHWEST ONCOLOGY GROUP STUDY
    SUTOW, WW
    SULLIVAN, MP
    FERNBACH, DJ
    CANGIR, A
    GEORGE, SL
    CANCER, 1975, 36 (05) : 1598 - 1602
  • [3] STUDY OF ADJUVANT CHEMOTHERAPY IN OSTEOGENIC SARCOMA
    SUTOW, WW
    SULLIVAN, MP
    WILBUR, JR
    CANGIR, A
    JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 15 (07): : 530 - 533
  • [4] ADJUVANT CHEMOTHERAPY FOR OSTEOGENIC-SARCOMA
    GOORIN, AM
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (02): : 113 - 115
  • [5] ADJUVANT CHEMOTHERAPY IN OSTEOGENIC-SARCOMA
    JAFFE, N
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (10) : 1179 - 1181
  • [6] ADJUVANT CHEMOTHERAPY FOR OSTEOGENIC-SARCOMA
    ETCUBANAS, E
    WILBUR, JR
    CANCER TREATMENT REPORTS, 1978, 62 (02): : 283 - 287
  • [7] THE DILEMMA OF ADJUVANT CHEMOTHERAPY FOR OSTEOGENIC-SARCOMA
    CARTER, SK
    CANCER CLINICAL TRIALS, 1980, 3 (01) : 29 - 36
  • [8] Adjuvant and neoadjuvant combination chemotherapy for osteogenic sarcoma
    Ferrari, Stefano
    Palmerini, Emanuela
    CURRENT OPINION IN ONCOLOGY, 2007, 19 (04) : 341 - 346
  • [9] ADJUVANT CHEMOTHERAPY IN OSTEOGENIC-SARCOMA - REPLY
    CARTER, SK
    JOURNAL OF CLINICAL ONCOLOGY, 1984, 2 (10) : 1181 - 1181
  • [10] PRIMARY OSTEOGENIC-SARCOMA - 8-YEAR EXPERIENCE WITH ADJUVANT CHEMOTHERAPY
    ROSEN, G
    MARCOVE, RC
    HUVOS, AG
    CAPARROS, BI
    LANE, JM
    NIRENBERG, A
    CACAVIO, A
    GROSHEN, S
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1983, 106 : 55 - 67
12345